Trevor J. Resnick, MD

July 19, 2021

The panelists discuss the possibility of treating Dravet syndrome in older children and adults and the effects if the therapies were effective.  

July 19, 2021

The panel discusses future gene therapies in development for Dravet syndrome.

July 06, 2021

Elaine Wirrell, MD, reviews the transition of care into adulthood of patients with Dravet syndrome and how this transition can affect the patient, caregiver, and care provider.

July 06, 2021

The panel discusses the impact on the family, siblings, or caregivers of patients with Dravet syndrome.

June 25, 2021

Elaine Wirrell, MD, provides background on fenfluramine, results from 2 clinical trials, and compares it to other treatment therapies.

June 25, 2021

Elizabeth Thiele, MD, PhD, reviews cannabidiol oral solution as treatment of seizures associated with Dravet syndrome and the safety profile and dosing associated with it.

June 18, 2021

Experts in the field discuss second- and third-line treatment options for Dravet syndrome such as stiripentol and vagal nerve stimulation and the effects they’ve seen on patients.

June 18, 2021

A panel discussion on the North American Consensus statement on treating Dravet syndrome and the approved therapies like clobazam, ketogenic diets, and other first- and second-line therapies.

June 11, 2021

A discussion on having conversations with the parents of patients with Dravet syndrome with regards to adjustments to therapy and managing their expectations.

June 11, 2021

A panel of experts discuss treatment goals for patients with Dravet syndrome and how to convey the variability of treatment to the parents of these patients.